Bryan J. McMichael's most recent trade in Coherus Biosciences Inc was a trade of 225,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 22, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Coherus Biosciences Inc | Bryan J. McMichael | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jan 2026 | 225,000 | 225,000 | - | - | Stock Option (Right to Buy) | |
| Coherus Biosciences Inc | Bryan J. McMichael | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jan 2026 | 112,500 | 133,736 (0%) | 0% | 0 | Common Stock | |
| Coherus Biosciences Inc | Bryan J. McMichael | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.55 per share. | 20 Jan 2026 | 1,715 | 21,236 (0%) | 0% | 1.5 | 2,658 | Common Stock |
| Coherus Biosciences Inc | Bryan J. McMichael | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2025 | 200,000 | 200,000 | - | - | Stock Option (Right to Buy) | |
| Coherus Biosciences Inc | Bryan J. McMichael | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.39 per share. | 20 Jan 2025 | 1,711 | 22,951 (0%) | 0% | 1.4 | 2,378 | Common Stock |
| Coherus Biosciences Inc | Bryan J. McMichael | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2025 | 160,000 | 160,000 | - | - | Stock Option (Right to Buy) | |
| Coherus Biosciences Inc | Bryan J. McMichael | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Aug 2024 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) | |
| Coherus Biosciences Inc | McMichael Bryan J. | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.44 per share. | 20 Jan 2024 | 1,707 | 22,972 (0%) | 0% | 2.4 | 4,165 | Common Stock |
| Coherus Biosciences Inc | Bryan McMichael J. | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.87 per share. | 07 Jan 2024 | 1,707 | 24,679 (0%) | 0% | 2.9 | 4,899 | Common Stock |
| Coherus Biosciences Inc | J. Bryan McMichael | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 125,000 | 125,000 | - | - | Stock Option (Right to Buy) | |
| Coherus Biosciences Inc | Bryan J. McMichael | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2023 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Coherus Biosciences Inc | Bryan J. McMichael | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2023 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Coherus Biosciences Inc | Bryan J. McMichael | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2023 | 12,500 | 26,386 (0%) | 0% | 0 | Common Stock | |
| Coherus Biosciences Inc | Bryan J. McMichael | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.58 per share. | 07 Jan 2023 | 1,699 | 13,886 (0%) | 0% | 9.6 | 16,276 | Common Stock |
| Coherus Biosciences Inc | Bryan J. McMichael | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2023 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Coherus Biosciences Inc | Bryan J. McMichael | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Sep 2022 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) |